Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
EventHumanPharmacovigilance

Estonian is available via eTranslation, the European Commission's machine translation service.

Translate to Estonian | Important information about machine translation

Date

Esmaspäev, 5 veebruar 2024, All day
Neljapäev, 8 veebruar 2024, All day

Asukoht

European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the PRAC meeting 5-8 February 2024

Draft Reference Number: EMA/PRAC/11237/2024 Corr.1

English (EN) (529.37 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Minutes of the PRAC meeting 5-8 February 2024

Adopted Reference Number: EMA/PRAC/122241/2024

English (EN) (875.86 KB - PDF)

Esmakordselt avaldatud:
Vaata

Share this page